Elevated METTL14 expression significantly enhanced pancreatic cancer cell proliferation and migration by directly targeting downstream p53 effector related to PMP-22 (PERP) mRNA in an m6A-dependent way [155, 156]. Here, TP53 is linked to pancreatic neoplasm.